Literature DB >> 19655145

HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study).

Mohamed Montacer Kchir1, Wafa Hamdi, Lilia Laadhar, Samir Kochbati, Dhia Kaffel, Kaouthar Saadellaoui, Houria Lahmar, Mohamed Mehdi Ghannouchi, Dhouha Azzouz, Lilia Daoud, Abdelmajid Ben Hamida, Béchir Zouari, Mondher Zitouni, Sondes Makni.   

Abstract

The objective of the study is to assess the distribution of HLA-B genes, HLA-B27 subtypes, HLA-DRB1 and HLA-DQB1 alleles in patients with ankylosing spondylitis (AS) and in control subjects in the Tunisian population and to compare their distribution with that found in other countries. This is a case-control study that included 100 consecutive patients (85 males/15 females) with AS according to the modified New York criteria and 100 control individuals. HLA-B, B27 subtypes and class II (DR and DQ) typing of all subjects was performed by polymerase chain reaction amplification with sequence-specific primers (PCR-SSP). HLA-B27 was found in 62% of patients against 3% in controls (P = 0.0000, OR = 52.6, 15.6 < CI < 166.7). On the other hand, B*07 and B*51 were significantly decreased in comparison with controls (P = 0.01, OR = 0.3, 0.1 < CI < 0.8 and P = 0.0000, OR = 0.2, 0.1 < CI < 0.4, respectively). Eight B*27 subtypes were identified in the AS group, but the most frequent ones were B*2702 (32%) and B*2705 (24%). Among HLA-DRB1 alleles, a significant increase in DRB1*11 was found in comparison with controls (P = 0.01, OR = 2.2, 1.2 < CI < 4.5). However, DRB1*13 had a negative association with AS (P = 0.01, OR = 0.4, 0.2 < CI < 0.8). For HLA-DQB1 alleles, a significant positive association with DQB1*03 was observed in AS group (P = 0.03, OR = 1.8, 1.0 < CI < 3.4). Multivariate analysis by logistic regression revealed that DRB1*11 and DQB1*03 had no direct links with the disease, but were dependent on the presence of HLA-B27. Moreover, B*07 and B*51 seemed to have independently a negative correlation with AS, but DRB1*13 seemed to depend on B*51. Haplotypes carrying B27 were significantly associated with AS and those carrying B*07 or B*51 were negatively correlated with the disease. In conclusion, our study confirms that B27 predisposes to AS while B*07 and B*51 are negatively correlated with the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655145     DOI: 10.1007/s00296-009-1079-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

Review 1.  Genetics of ankylosing spondylitis.

Authors:  M A Brown; B P Wordsworth; J D Reveille
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

2.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

Review 3.  HLA-B27 and genetic predisposing factors in spondyloarthropathies.

Authors:  J D Reveille; E J Ball; M A Khan
Journal:  Curr Opin Rheumatol       Date:  2001-07       Impact factor: 5.006

4.  HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles.

Authors:  B Silva-Ramírez; G Vargas-Alarcón; J Granados; R Burgos-Vargas
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  Non-B27 MHC associations of ankylosing spondylitis.

Authors:  A-M Sims; M Barnardo; I Herzberg; L Bradbury; A Calin; B P Wordsworth; C Darke; M A Brown
Journal:  Genes Immun       Date:  2006-12-14       Impact factor: 2.676

Review 6.  The genetics of spondyloarthropathies.

Authors:  Maxime Breban; Corinne Miceli-Richard; Elena Zinovieva; Dominique Monnet; Roula Said-Nahal
Journal:  Joint Bone Spine       Date:  2006-03-20       Impact factor: 4.929

7.  HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients.

Authors:  J C C Wei; W C Tsai; H S Lin; C Y Tsai; C T Chou
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

Review 8.  Breakthroughs in genetic studies of ankylosing spondylitis.

Authors:  M A Brown
Journal:  Rheumatology (Oxford)       Date:  2007-11-22       Impact factor: 7.580

9.  Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients.

Authors:  G Vargas-Alarcón; J D Londoño; G Hernández-Pacheco; C Pacheco-Tena; E Castillo; M H Cardiel; J Granados; R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

10.  HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela.

Authors:  Ana Cipriani; Sergio Rivera; Manzur Hassanhi; Georgina Márquez; Rosaura Hernández; Cecilia Villalobos; Milagros Montiel
Journal:  Hum Immunol       Date:  2003-07       Impact factor: 2.850

View more
  11 in total

Review 1.  Revisiting MHC genes in spondyloarthritis.

Authors:  Maxime Breban; Félicie Costantino; Claudine André; Gilles Chiocchia; Henri-Jean Garchon
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  Association and frequency of HLA-A, B and HLA-DR genes in south Tunisian patients with spondyloarthritis (SpA).

Authors:  Nadia Mahfoudh; Mariam Siala; Markus Rihl; Arwa Kammoun; Faten Frikha; Hela Fourati; Mohamed Younes; Radhouane Gdoura; Lilia Gaddour; Faiza Hakim; Zouheir Bahloul; Sofien Baklouti; Naceur Bargaoui; Sleheddine Sellami; Adnene Hammami; Hafedh Makni
Journal:  Clin Rheumatol       Date:  2011-03-01       Impact factor: 2.980

3.  Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis.

Authors:  Hai Lin; Yi-Zhen Gong
Journal:  Rheumatol Int       Date:  2017-05-19       Impact factor: 2.631

Review 4.  Spondyloarthritis in North Africa: an update.

Authors:  Samy Slimani; Wafa Hamdi; Kawtar Nassar; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2021-02-09       Impact factor: 2.980

5.  Multi-modal Binding of a 'Self' Peptide by HLA-B*27:04 and B*27:05 Allelic Variants, but not B*27:09 or B*27:06 Variants: Fresh Support for Some Theories Explaining Differential Disease Association.

Authors:  Manish Kumar Rana; Manni Luthra-Guptasarma
Journal:  Protein J       Date:  2016-10       Impact factor: 2.371

6.  Prevalence of HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis.

Authors:  Amal Akassou; Hanae Yacoubi; Afaf Jamil; Nadia Dakka; Saaïd Amzazi; Khalid Sadki; Redouane Niamane; Selma Elhassani; Youssef Bakri
Journal:  Rheumatol Int       Date:  2015-08-07       Impact factor: 2.631

Review 7.  HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps.

Authors:  Nelly Raymond Ziade
Journal:  BMC Musculoskelet Disord       Date:  2017-06-29       Impact factor: 2.362

8.  Ankylosing spondylitis: analysis of gene-gene interactions between IL-12β, JAK2, and STAT3 in Han Chinese and Algerian cohorts.

Authors:  Ahlem Saadi; Jie Dang; Shan Shan; Aicha Ladjouze-Rezig; Salima Lefkir-Tafiani; Yaoqin Gong; Qiji Liu; Traki Benhassine
Journal:  Cent Eur J Immunol       Date:  2019-04-15       Impact factor: 2.085

Review 9.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

10.  Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab.

Authors:  Akiyo Otsuka; Mitsuhiro Morita; Harumoto Yamada
Journal:  J Orthop Sci       Date:  2015-08-06       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.